Ljungberg T
Department of Pharmacology, Karolinska Institute, Stockholm, Sweden.
Pharmacol Biochem Behav. 1989 Jul;33(3):709-12. doi: 10.1016/0091-3057(89)90412-7.
The specific dopamine (DA) D-1 receptor antagonist SCH 23390 was found to attenuate operant lever-pressing with water as reward in a dose-dependent manner and more potently than drinking itself. This effect occurred in the same fashion as previously reported for DA D-2 antagonists. In contrast to the DA D-2 antagonist haloperidol, the attenuated operant lever-pressing induced by the DA D-1 antagonist SCH 23390 was not counteracted by the anticholinergic drug scopolamine. The decreased water intake in thirsty animals caused by a low dose of apomorphine was not antagonised by SCH 23390. This has previously been found with DA D-2 antagonists, such as haloperidol and sulpiride. The results show that in spite of some similarities in the behavioural effects of DA D-1 and D-2 antagonists, a closer pharmacological analysis is able to reveal pronounced differences.